scholarly article | Q13442814 |
P50 | author | Helen Weiss | Q73218764 |
Kevin Wing | Q88040188 | ||
Wanjiku Mathenge | Q104776906 | ||
Matthew J Burton | Q30513794 | ||
Tunde Peto | Q52930469 | ||
David Macleod | Q59670235 | ||
P2093 | author name string | Allen Foster | |
Andrew Bastawrous | |||
Hannah Kuper | |||
Hillary Rono | |||
Nisha Shah | |||
P2860 | cites work | Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration | Q64461527 |
Incidence and progression rates of age-related maculopathy: the Rotterdam Study | Q64461578 | ||
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study | Q73043468 | ||
Racial differences and other risk factors for incidence and progression of age-related macular degeneration: Salisbury Eye Evaluation (SEE) Project | Q80670203 | ||
The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study | Q81536039 | ||
The Nakuru eye disease cohort study: methodology & rationale | Q33624678 | ||
Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies | Q33785443 | ||
Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study | Q34594919 | ||
Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study | Q35175466 | ||
The epidemiology of age-related macular degeneration in the Indian subcontinent | Q37328320 | ||
Global estimates of visual impairment: 2010. | Q37963651 | ||
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group | Q40440695 | ||
The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study | Q44164361 | ||
Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. | Q44980248 | ||
5-year incidence of age-related maculopathy in the Reykjavik Eye Study | Q45035657 | ||
Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study | Q45721138 | ||
14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study | Q46475994 | ||
Age-related macular degeneration | Q59446738 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Kenya | Q114 |
eye disease | Q3041498 | ||
macular degeneration | Q27429789 | ||
P1104 | number of pages | 8 | |
P304 | page(s) | 631-638 | |
P577 | publication date | 2017-06-01 | |
P1433 | published in | JAMA Ophthalmology | Q4787301 |
P1476 | title | Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study | |
P478 | volume | 135 |
Q93101251 | Incidence of Visually Impairing Cataracts Among Older Adults in Kenya |
Q51758411 | Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study. |
Q64060594 | Role of inflammatory factors in the effects of aflibercept or ranibizumab treatment for alleviating wet age-associated macular degeneration |
Search more.